Drug adherence and psychological factors in patients with apparently treatment‐resistant hypertension: Yes but which ones?

Autor: Coralie M. G. Georges, Marco Pappaccogli, Elvira Fanelli, Géraldine Petit, Sabrina Ritscher, Marilucy Lopez‐Sublet, Achille Bapolisi, Pierre Wallemacq, Franco Rabbia, Philippe de Timary, Stefan W. Toennes, Alexandre Persu

Publikováno v: The Journal of Clinical Hypertension. 24:1436-1443

The aim of the study was to assess drug adherence, as well as association of psychological factors with both drug adherence and severity of hypertension in two subtypes of patients with apparently treatment-resistant hypertension (ATRH): younger pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b52750116e31933fa61d8a796e1758
https://doi.org/10.1111/jch.14575

Real-world Retrospective Claims Database Analysis (REACT) of the COVID-19 Pandemic Impact on COPD Exacerbations in the USA

Autor: S. Pirondi, D. Galkin, A. Guasconi, J. Imperato, R. Hermans, G. Georges

Publikováno v: A51. MANAGEMENT AND IMPACT OF THE COVID-19 PANDEMIC ON RESPIRATORY HEALTH.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3fa8c2e8344390f8fcc8b6e7e5baa58
https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1820

Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients

Autor: D Price, W Henley, V Carter, D Skinner, R Vella, A Papi, L M Fabbri, H A Kerstjens, N Roche, D Singh, C F Vogelmeier, E Şen, J E D Cançado, M Kots, E Nudo, S Barile, G Georges

Publikováno v: 05.01 - Airway pharmacology and treatment.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e4e1d5812f2e4109d80ac52a923ba32
https://doi.org/10.1183/13993003.congress-2022.1552

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Autor: Pageaux, G. (Georges-Philippe), Nzinga, C. (Clovis Lusivika), Ganne, N. (Nathalie), Samuel, D. (Didier), Dorival, C. (Céline), Zoulim, F. (Fabien), Cagnot, C. (Carole), Decaens, T. (Thomas), Thabut, D. (Dominique), Asselah, T. (Tarik), Mathurin, P. (Philippe), Habersetzer, F. (Francois), Bronowicki, J. (Jean-Pierre), Guyader, D. (Dominique), Rosa, I. (Isabelle), Leroy, V. (Vincent), Chazouilleres, O. (Olivier), de Ledinghen, V. (Victor), Bourliere, M. (Marc), Causse, X. (Xavier), Cales, P. (Paul), Metivier, S. (Sophie), Loustaud-Ratti, V. (Véronique), Riachi, G. (Ghassan), Alric, L. (Laurent), Gelu-Simeon, M. (Moana), Minello, A. (Anne), Gournay, J. (Jérôme), Geist, C. (Claire), Tran, A. (Albert), Abergel, A. (Armand), Portal, I. (Isabelle), d'Alteroche, L. (Louis), Raffi, F. (François), Fontaine, H. (Hélène), Carrat, F. (Fabrice), Pol, S. (Stanislas), Baumert, Thomas F., Doffoel, M. (Michel), Mutter, C. (Catherine), Simo-Noumbissie, P. (Pauline), Razi, E. (Esma)

Publikováno v: BMC Infectious Diseases
BMC Infectious Diseases, BioMed Central, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-12 (2022)

Background In HCV-infected patients with advanced liver disease, the direct antiviral agents-associated clinical benefits remain debated. We compared the clinical outcome of patients with a previous history of decompensated cirrhosis following treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a64389812730cdee1f356f6f46786008
https://hal.archives-ouvertes.fr/hal-03555553/document